Zacks Research Issues Negative Forecast for MD Earnings

Pediatrix Medical Group, Inc. (NYSE:MD) – Equities researchers at Zacks Research reduced their Q2 2025 earnings per share (EPS) estimates for Pediatrix Medical Group in a note issued to investors on Thursday, June 12th. Zacks Research analyst R. Department now forecasts that the company will post earnings of $0.38 per share for the quarter, down from their previous estimate of $0.39. The consensus estimate for Pediatrix Medical Group’s current full-year earnings is $1.38 per share. Zacks Research also issued estimates for Pediatrix Medical Group’s Q3 2025 earnings at $0.36 EPS, Q4 2025 earnings at $0.37 EPS, Q2 2026 earnings at $0.38 EPS and FY2026 earnings at $1.37 EPS.

Pediatrix Medical Group (NYSE:MD) last posted its quarterly earnings results on Tuesday, May 6th. The company reported $0.33 EPS for the quarter, beating analysts’ consensus estimates of $0.25 by $0.08. The business had revenue of $458.36 million for the quarter, compared to analysts’ expectations of $451.44 million. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. The business’s quarterly revenue was down 7.4% on a year-over-year basis. During the same period last year, the firm earned $0.20 earnings per share.

Several other research firms have also commented on MD. Macquarie lifted their price target on Pediatrix Medical Group from $19.00 to $20.00 and gave the stock an “outperform” rating in a research report on Thursday, May 8th. UBS Group dropped their price target on Pediatrix Medical Group from $18.50 to $16.00 and set a “neutral” rating for the company in a research report on Monday, May 12th. Finally, Truist Financial dropped their price target on Pediatrix Medical Group from $18.00 to $16.00 and set a “hold” rating for the company in a research report on Friday, April 11th. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $16.67.

Pediatrix Medical Group Trading Down 1.6%

Shares of MD stock opened at $14.02 on Monday. Pediatrix Medical Group has a 12-month low of $6.62 and a 12-month high of $17.67. The company has a current ratio of 1.60, a quick ratio of 1.42 and a debt-to-equity ratio of 0.81. The stock’s 50-day moving average price is $13.69 and its 200-day moving average price is $13.98. The stock has a market capitalization of $1.20 billion, a price-to-earnings ratio of -11.68, a price-to-earnings-growth ratio of 1.74 and a beta of 1.27.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the business. XTX Topco Ltd purchased a new position in shares of Pediatrix Medical Group during the fourth quarter valued at approximately $169,000. Principal Financial Group Inc. boosted its holdings in shares of Pediatrix Medical Group by 7.5% in the fourth quarter. Principal Financial Group Inc. now owns 551,924 shares of the company’s stock valued at $7,241,000 after purchasing an additional 38,306 shares during the period. Deutsche Bank AG boosted its holdings in shares of Pediatrix Medical Group by 53.1% in the fourth quarter. Deutsche Bank AG now owns 74,023 shares of the company’s stock valued at $971,000 after purchasing an additional 25,663 shares during the period. Smartleaf Asset Management LLC boosted its holdings in shares of Pediatrix Medical Group by 750.9% in the fourth quarter. Smartleaf Asset Management LLC now owns 6,901 shares of the company’s stock valued at $91,000 after purchasing an additional 6,090 shares during the period. Finally, New York State Teachers Retirement System boosted its holdings in shares of Pediatrix Medical Group by 3.3% in the fourth quarter. New York State Teachers Retirement System now owns 130,786 shares of the company’s stock valued at $1,716,000 after purchasing an additional 4,212 shares during the period. Hedge funds and other institutional investors own 97.71% of the company’s stock.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.